Roche MH, López BOJ

Idioma: Español
Referencias bibliográficas: 22
Paginas: 77-79
Archivo PDF: 85.91 Kb.

FRAGMENTO

Sr. Editor:

Cada día se presentan más casos con un elevado número de factores de riesgo perjudiciales para la salud: el hábito de fumar es uno de estos factores. En la atención al paciente con cardiopatía estos se acentúan, con mayor daño para los enfermos, y elevación de los costos sanitarios, relacionados con las complicaciones, la estadía hospitalaria, y la reincorporación a la sociedad.

REFERENCIAS (EN ESTE ARTÍCULO)

1. World Health Organization. World Health Statistics 2010 [Internet]. 2010 [cited Jul 15th 2011]. Available at: www.who.int/entity/whosis/whostat/EN_WHS10_Full.pdf

2. Regueira G, Suárez-Lugo N, Jakimczuk S. Tobacco control strategies from a gender perspective in Latin America. Salud Pública Mex. 2010;52(2):315-30.

3. Texas Heart Institute. Heart Disease Risk Factors. [Internet]. 2011 [cited Jul 15th 2011]. Available at: http://www.texasheartinstitute.org/HIC/Topics/HSmart/riskfact.cfm

4. D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascu-lar risk profile for use in primary care. The Framing-ham Heart Study. Circulation. 2008;117(6):743-53.

5. Aladro Miranda IF. Clinical, electrical and echocar-diographic assessment of patients undergoing coro-nary angioplasty with stent implantation. [Work for the completion of specialty] Celestino Hernández Robau University Hospital. Villa Clara: UCM; 2007.

6. Piñón P, Kaski JC. Inflammation, atherosclerosis and cardiovascular disease risk: PAPP-A, Lp-PLA2 and cystatin C. New insights or redundant infor-mation? Rev Esp Cardiol. 2006;59:247-58.

7. Ross R. Atherosclerosis - An inflammatory disease. N Engl J Med. 1999;340(2):115-26.

8. Sitia S, Tomasoni L, Atzeni F, Ambrosio G, Cor-diano C, Catapano A, et al. From endothelial dys-function to atherosclerosis. Autoimmun Rev. 2010; 9(12):830-4.

9. Rautou PE, Vion AC, Amabile N, Chironi G, Simon A, Tedgui A, et al. Microparticles, vascular function, and atherothrombosis. Circ Res. 2011;109(5):593-606.

10. Mannan H, Stevenson C, Peeters A, Walls H, McNeil J. Framingham risk prediction equations for incidence of cardiovascular disease using detailed measures for smoking. Heart Int. 2010;5:e11.49-57.

11. Tuñón J, Egido J. Endothelial Dysfunction, Inflam-mation, and Statins: New Evidence. Rev Esp Car-diol. 2004;57(10):903-5.

12. Guarino F, Cantarella G, Caruso M, Russo C, Mancuso S, Arcidiacono G, et al. Endothelial acti-vation and injury by cigarette smoke exposure. J Biol Regul Homeost Agents. 2011;25(2):259-68.

13. Nguyen AB, Rohatgi A, Garcia CK, Ayers CR, Das SR, Lakoski SG, et al. Interactions between smo-king, pulmonary surfactant protein B, and atheros-clerosis in the general population: the Dallas Heart Study. Arterioscler Thromb Vasc Biol. 2011;31(9): 2136-43.

14. Balanescu S, Calmac L, Constantinescu D, Mari-nescu M, Onut R, Dorobantu M. Systemic inflam-mation and early atheroma formation: are they related? Maedica (Buchar). 2010;5(4):292-301.

15. Centers for Disease Control and Prevention (CDC). Current cigarette smoking prevalence among wor-king adults – United States, 2004-2010. MMWR Morb Mortal Wkly Rep. 2011;60(38):1305-9.

16. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet. 2011;378(9799):1297-305.

17. Norhammar A, Malmberg K, Diderholm E, Lagerq-vist B, Lindahl B, Rydén L, et al. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revas-cularization. J Am Coll Cardiol. 2004;43(4):585-91.

18. Aguilar C, Vázquez C, Gamboa R, García N, Ríos JJ, Holguen R, et al. Obesity, diabetes, hyperten-sion and tobacco consumption in an urban adult Mexican population. Arch Med Res. 2001;32(5): 446-53.

19. Hochholzer W, Trenk D, Mega JL, Morath T, Stratz C, Valina CM, et al. Impact of smoking on anti-platelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy. Am Heart J. 2011;162(3):518-26.e5.

20. Singh RB, Fedacko J, Vargova V, Kumar A, Mohan V, Pella D, et al. Singh's verbal autopsy questionnaire for the assessment of causes of death, social autopsy, tobacco autopsy and dietary autopsy, based on medical records and interview. Acta Cardiol. 2011;66(4):471-81.

21. Pichon-Riviere A, Augustovski F, Bardach A, Colantonio L; Latinclen Tobacco Research Group. Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America. Value Health. 2011;14(5 Suppl 1):S51-9.

22. Villalbí JR, Castillo A, Cleries M, Saltó E, Sánchez E, Martínez R, et al; Barcelona Group. Acute myo-cardial infarction hospitalization statistics: Apparent decline accompanying an increase in smoke-free areas. Rev Esp Cardiol. 2009;62:812-5.